2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trialIan Smith, Martine Piccart, Aron Goldhirsch et al.|The Lancet|2007Cited by 1.5k
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancerEugen Ruckhäberle, Manfred Kaufmann, Achim Rody et al.|Breast Cancer Research and Treatment|2007Cited by 297
Ceramide synthases and ceramide levels are increased in breast cancer tissueSusanne Schiffmann, Sabine Grösch, Jessica Sandner et al.|Carcinogenesis|2009Cited by 232